ActiTrexx GmbH is a startup based in Germany, most recent round Series A, 1 tracked investor.
ActiTrexx GmbH is a company founded in 2020 headquartered in Germany. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
ActiTrexx develops activated regulatory T cells (ATreg) to prevent rejection reactions in patients undergoing stem cell transplants and to treat autoimmune diseases by rebalancing dysregulated immune systems.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.